AXL in Metastatic Ovarian Cancer Tumors is a Targetable Biomarker Associated with Chemoresistance and Poor Prognosis

M. M. Mullen,J. M. Quinn,M. Greenwade,G. Opara,H. Beck-Noia,I. S. Hagemann,A. R. Hagemann,L. M. Kuroki,C. K. McCourt,P. H. Thaker,M. A. Powell,D. G. Mutch,K. C. Fuh

Gynecologic oncology（2019）

引用 0|浏览50

暂无评分

摘要

Objective: The aim of this study was to determine the association between AXL expression in primary and metastatic tumor samples and clinical outcomes, in order to establish a predictive and prognostic biomarker in ovarian cancer patients

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要